Cellectar Biosciences Inc
NASDAQ:CLRB

Watchlist Manager
Cellectar Biosciences Inc Logo
Cellectar Biosciences Inc
NASDAQ:CLRB
Watchlist
Price: 0.2978 USD 2.06% Market Closed
Market Cap: 13.7m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

CLRB Price Targets Summary
Cellectar Biosciences Inc

Wall Street analysts forecast CLRB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLRB is 3.06 USD with a low forecast of 3.03 USD and a high forecast of 3.15 USD.

CLRB Lowest Forecast
Wall Street Target
3.03 USD
917% Upside
CLRB Average Forecast
Wall Street Target
3.06 USD
928% Upside
CLRB Highest Forecast
Wall Street Target
3.15 USD
958% Upside
Lowest
Price Target
3.03 USD
917% Upside
Average
Price Target
3.06 USD
928% Upside
Highest
Price Target
3.15 USD
958% Upside
Cellectar Biosciences Inc Competitors:
Price Targets
OPK
OPKO Health Inc
148% Upside
IMMX
Immix Biopharma Inc
220% Upside
NIOX
Niox Group PLC
27% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
37% Upside
OPK
OPKO Health Inc
148% Upside
IMMX
Immix Biopharma Inc
220% Upside
NIOX
Niox Group PLC
27% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
37% Upside
STOK
Stoke Therapeutics Inc
97% Upside
DSGN
Design Therapeutics Inc
92% Upside
B
251120
Bio-FD&C Co Ltd
4% Downside
NTRA
Natera Inc
20% Upside

Revenue
Forecast

Revenue Estimate
Cellectar Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Cellectar Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Cellectar Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
What are analyst estimates?

See Also

Summary
CLRB intrinsic value, competitors valuation, and company profile.
DCF Valuation
CLRB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CLRB stock valuation using valuation multiples.
Wall Street Estimates
CLRB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CLRB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLRB's stock price target?
Price Target
3.06 USD

According to Wall Street analysts, the average 1-year price target for CLRB is 3.06 USD with a low forecast of 3.03 USD and a high forecast of 3.15 USD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 263,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.